Latest Headlines

  1. Illumina DRAGEN v4.4 Powers Clinical Oncology Research And Multiomic Applications 5/13/2025

    Illumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ version 4.4 software (v4.4), the industry's most comprehensive secondary analysis solution. The latest version of DRAGEN includes out-of-the-box oncology applications for clinical research and support for newly announced Illumina multiomics assays.

  2. Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems 5/13/2025

    Daxor Corporation (Nasdaq: DXR), Daxor Corporation, the global leader in blood volume measurement technology, announces the expansion of its innovative diagnostic solutions into two additional U.S. healthcare systems, further advancing the standard of care for cardiovascular and critical care patients nationwide.

  3. Countable Labs Launches Category-Defining, Highly Sensitive PCR Platform — Countable PCR — Finally Quantifying Rare Events, Even From Limited Samples 5/13/2025

    Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection.

  4. QIAGEN Enhances Leading Clinical Genomics Portfolio With Acquisition Of Genoox AI-Powered Software 5/12/2025

    QIAGEN today announced it has signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.

  5. Agappe Diagnostics And Fujirebio- Japan: Advancing CLEIA-Based Immunoassay Testing 5/12/2025

    In a groundbreaking collaboration, Agappe Diagnostics Ltd and Fujirebio Inc., Japan are reshaping the future of laboratory diagnostics.

  6. Solution 2.8.0 Release For The Prime Liquid Handler 5/9/2025

    At HighRes Biosolutions, our commitment to innovation drives us to continuously refine our software solutions, ensuring they meet the evolving needs of modern laboratories.

  7. OmniAb Introduces The xPloration Partner Access Program 5/8/2025

    OmniAb, Inc. today introduced the launch of the xPloration Partner Access Program, under which current OmniAb partners can purchase the xPloration instrument to significantly enhance their capabilities in antibody discovery and development.

  8. Nordic Bioscience Announces PRO-C3 Launched By Roche Diagnostics On Cobas Analysers 5/8/2025

    Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT formula (age, diabetes status, PRO-C3, platelets), assesses liver fibrosis severity – a disease responsible for approximately one in every 25 deaths worldwide.

  9. Eurofins Viracor Revolutionizes Respiratory Diagnostics With New BAL Specimen Type For NeXGen® Fungal / AFB NGS Assay 5/7/2025

    Eurofins Viracor, a leading specialty diagnostics laboratory, is proud to announce a groundbreaking advancement in respiratory infection diagnostics with the launch of a new bronchoalveolar lavage (BAL) specimen type for its NeXGen® Fungal / Acid Fast Bacteria Next Generation Sequencing (NGS) assay.

  10. Histofy And Source Bioscience UK Announce Strategic Partnership To Advance AI-Powered Pathology In The UK 5/6/2025

    Histofy, a leading UK based pathology AI company focused on accelerating histopathology workflows in both clinical and pharmaceutical sectors, is proud to announce a strategic partnership with Source BioScience UK Limited, the largest histopathology service provider in the United Kingdom.